Intermediate care in nursing home
ISRCTN | ISRCTN21608185 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN21608185 |
Secondary identifying numbers | N/A |
- Submission date
- 19/07/2013
- Registration date
- 26/07/2013
- Last edited
- 12/08/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Signs and Symptoms
Plain English summary of protocol
Background and study aims
Intermediate care services are thought to provide adequate care closer to home, preventing hospital admissions and facilitating early discharge. The goal of this study is to assess the effectiveness of intermediate care services. We will compare patients transferred to intermediate care service with patients staying in hospital. The study's findings will help us choose the correct treatment and care for elderly persons with acute illness.
Who can participate?
The study recruited men and women 70 years and older, living at home who were admitted to hospital for acute illness in Bergen, Norway. Patients could participate if they had a medical or orthopedic condition (disorders related to muscles and joints) which did not require surgery or intensive care.
What does the study involve?
Patients were randomly allocated to be either treated in hospital as usual or transferred to intermediate care in a nursing home unit for a stay of maximum three weeks. For the next 12 months, patients' mortality, subsequent admissions to hospital or nursing home and use of home care serviceswere recorded
What are the possible benefits and risks of participating?
A potential benefit in transfer to intermediate care could be longer stay before returning home. A potential disadvantage could be less access to diagnostic procedures like x-ray.
The two treatment options were considered equally safe and appropriate for these patients.
Where is the study run form?
The study was initiated by Bergen municipality, Haraldsplass Deaconess Hospital and Haukeland University Hospital and set up in cooperation with Kavli Research Centre for Ageing and Dementia and Institute of Medicine, University of Bergen, Norway. Centers taking part in the study are Storetveit Nursing Home, Haraldsplass Deaconess Hospital and Haukeland University Hospital, all located in Bergen, Norway.
When is the study starting and how long is it expected to run for?
Recruitment started in August 2007 and ended in June 2008. The study period lasted for a further 12 months after enrolment of the last patient.
Who is funding the study?
Funding has been provided by The Western Norway regional Health Authorityand Kavli Research Centre for Ageing and Dementia.
Who is the main contact?
Dr Jo Kåre Herfjord
fmhojkh@fylkesmannen.no
Contact information
Scientific
Fylkesmannen i Hordaland
Kaigaten 9
Bergen
5020
Norway
fmhojkh@fylkesmannen.no |
Study information
Study design | Parallel-group randomized intervention study. Blinding was not possible. The setting of the study and data collection took place at a nursing home and two hospitals. |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised parallel trial |
Study setting(s) | Other |
Study type | Treatment |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | Intermediate care in nursing home after hospital admission: a randomized controlled trial with one year follow-up |
Study objectives | The objective of the study is to evaluate effect and safety of early transfer to community-based intermediate care, compared to traditional hospital treatment. |
Ethics approval(s) | The Regional Committee for Medical Research Ethics in Norway approved the study on 21/05/2007, ref: S-07096a. Extension of the observation period and new outcome measures were approved on 24/09/2009, ref: 2009/821. |
Health condition(s) or problem(s) studied | Acute illness or trauma in frail elderly patients with co-morbidity, resulting in hospital admission. Choice of post-acute management and care. Collaboration between hospital and community health services. |
Intervention | 1. Patients in the intervention group went to intermediate care unit within the next working day after randomization. A multi-disciplinary team of physicians, nurse and physiotherapists examined each patient after a model of comprehensive geriatric assessment. As well as continuing treatment for the acute illness or injury, therapy focused on mobilization, physical exercise, optimal nutrition and critical evaluation of prescribed medication. The aim was maximum independence, enabling patients to resume living at home. Information about home situation and caregivers were obtained and if necessary increased home care services were requested. Length of stay in the unit was limited to maximum 3 weeks 2. Patients in the control group received usual care in hospital. For both treatment arms there was a follow-up period of 12 months. |
Intervention type | Other |
Primary outcome measure | Our pre-specified primary outcome was the number of days patients would be alive and living at home throughout the first year after randomization. Data were obtained from patient registers at the hospitals and the community health care services for a period of 365 days for each patient after randomization. |
Secondary outcome measures | Secondary outcome measures were mortality, days spent in hospital, days in nursing homes and use of home care services. |
Overall study start date | 15/08/2007 |
Completion date | 02/06/2009 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Senior |
Sex | Both |
Target number of participants | 400 |
Key inclusion criteria | 1. Patients aged 70 years or older 2. Living at home 3. Resident in Bergen municipality 4. Acutely admitted to medical or orthopaedic departments 5. Respiratory and circulatory stable 6. Deemed able to return home within three weeks 7. Intermediate care considered suitable by attending physician |
Key exclusion criteria | 1. Severe dementia 2. Delirium 3. Need for surgery or intensive care treatment |
Date of first enrolment | 15/08/2007 |
Date of final enrolment | 01/06/2008 |
Locations
Countries of recruitment
- Norway
Study participating centre
5020
Norway
Sponsor information
Research organisation
Haraldsplass Deaconess Hospital
Ulriksdal 8
Bergen
5009
Norway
ida.kristine.sangnes@haraldsplass.no | |
Website | http://kavlisenter.no/index.aspx?pageId=1 |
https://ror.org/03t3p6f87 |
Funders
Funder type
Government
No information available
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 09/12/2014 | Yes | No |